Search clinical trials for: PERT-IJS plus trastuzumab, carboplatin and docetaxel
Total 931 results
-
Biocon Biologics UK LtdNot yet recruitingHR Negative HER2 Positive Early Breast Cancer or Locally Advanced Breast Cancer Patients
-
Jonsson Comprehensive Cancer CenterCompletedBreast CancerUnited States
-
Henan Cancer HospitalCompletedHER2 Positive Breast CancerChina
-
Genentech, Inc.Completed
-
Henan Cancer HospitalRecruitingBreast Cancer | HER2-positive Breast CancerChina
-
Cancer Trials IrelandCompleted
-
Peking University People's HospitalRecruitingHER2-positive Early Breast CancerChina
-
University of Medicine and Dentistry of New JerseyNational Cancer Institute (NCI); Aventis PharmaceuticalsTerminated
-
Hebei Medical University Fourth HospitalOrigiMedRecruitingProspective | ObservationalChina
-
Shandong UniversityUnknownHER2-positive Breast Cancer
-
Jonsson Comprehensive Cancer CenterGenentech, Inc.; Aventis PharmaceuticalsCompleted
-
University of MiamiAventis PharmaceuticalsCompletedBreast CancerUnited States
-
Guangdong Provincial People's HospitalCompletedHER2-Positive Breast CancerChina
-
Finnish Breast Cancer GroupCompleted
-
Henan Cancer HospitalRecruitingBreast Cancer,Her2 PositiveChina
-
PfizerCompletedEarly Breast CancerCzechia, Serbia, Slovakia, United States, Belarus, Hungary, Ukraine, Italy, Poland, Russian Federation
-
Translational Oncology Research InternationalNational Cancer Institute (NCI); University of California, Los AngelesCompleted
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedBreast CancerUnited States
-
Fudan UniversityCompleted
-
Case Comprehensive Cancer CenterCompletedBreast CancerUnited States
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruitingMetastatic Breast CancerChina
-
Shanghai Institute Of Biological ProductsFudan UniversityCompletedHER2-positive Early Breast CancerChina
-
Georgetown UniversityRecruitingNon-metastatic Breast Cancer | Cancer Related Cognitive DeclineUnited States
-
European Organisation for Research and Treatment...GlaxoSmithKlineCompletedBreast CancerFrance, United Kingdom, Belgium, Switzerland, Slovenia
-
Zhe Jiang Hisun Bioray Bio-pharmaceu tical Co.LtdUnknown
-
Danish Breast Cancer Cooperative GroupSanofi; Hoffmann-La RocheUnknown
-
Austrian Breast & Colorectal Cancer Study GroupHoffmann-La Roche; CephalonCompleted
-
Fudan UniversityRecruitingMetastatic Breast Cancer | HER2-positive Breast CancerChina
-
National Cancer Institute, NaplesActive, not recruitingMetastatic Breast CancerItaly
-
Shanghai Jiao Tong University School of MedicineShanghai 10th People's Hospital; Jiangxi Provincial Cancer Hospital; Shanghai... and other collaboratorsRecruitingRecurrent Non-small Cell Lung CancerChina
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedBreast CancerUnited States, Canada
-
Vector OncologyEisai Inc.TerminatedHER-2 Positive Breast CancerUnited States
-
Novartis PharmaceuticalsTerminatedNeoplasms, BreastUnited States, France, Ireland
-
Chinese PLA General HospitalUnknownNeoplasms, Therapy-AssociatedChina
-
Henan Cancer HospitalWithdrawnBreast Cancer | HER2-positive Breast CancerChina
-
Zhenzhen LiuRecruitingBreast Cancer | Triple Negative Breast Cancer | CamrelizumabChina
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
Gruppo Oncologico Italiano di Ricerca ClinicaMipharm SpA; Temas srl; Clirest s.r.l.; University Hospital of Parma: Department... and other collaboratorsUnknown
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)CompletedBreast CancerUnited States
-
SanofiCompleted
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
Guangdong Provincial People's HospitalRecruitingNeoadjuvant Therapies for HER2+ Breast CancerChina
-
Jiangsu HengRui Medicine Co., Ltd.Shanghai Pulmonary Hospital, Shanghai, ChinaTerminatedNon Squamous Non Small Cell LungChina
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Active, not recruiting
-
Shanghai Zhongshan HospitalCompleted
-
Hoffmann-La RocheTerminatedMetastatic Breast CancerTaiwan, Korea, Republic of, Thailand, Malaysia
-
National Cancer Institute (NCI)NRG OncologyCompletedEsophageal Adenocarcinoma | Gastroesophageal Junction Adenocarcinoma | Stage IIA Esophageal Cancer AJCC v7 | Stage IIB Esophageal Cancer AJCC v7 | Stage IIIA Esophageal Cancer AJCC v7 | Stage IIIB Esophageal Cancer AJCC v7 | Stage IB Esophageal Cancer AJCC v7United States
-
Intergroupe Francophone de Cancerologie ThoraciqueCompletedNon Small Cell Lung Cancer Metastatic | HER2 Gene Mutation | Non Small Cell Lung Cancer Stage IIIFrance
-
Thomas HatschekActive, not recruitingEarly-Stage Breast Carcinoma | HER-2 Positive Breast CancerSweden
-
King Faisal Specialist Hospital & Research CenterCompleted